Open access
255
Views
4
CrossRef citations to date
0
Altmetric
REVIEW
Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging Data
Larissa Hauer1 Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Christian Doppler Medical Center, Paracelsus Medical University, Salzburg, Austria
& Johann Sellner2 Department of Neurology, Landesklinikum Mistelbach-Gänserndorf, Mistelbach, AustriaCorrespondence[email protected]
https://orcid.org/0000-0001-8749-5533
Pages 3915-3927
|
Received 09 Jul 2022, Accepted 03 Nov 2022, Published online: 05 Dec 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.